{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:34:29Z","timestamp":1786984469093,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.anndiagpath.2024.152398","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T05:13:06Z","timestamp":1731129186000},"page":"152398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["PIT-1\/SF-1 co-expression in pituitary neuroendocrine tumors (PitNETs) with comprehensive review of the literature: How should we best characterize these neoplasms?"],"prefix":"10.1016","volume":"74","author":[{"given":"Christina Abi","family":"Faraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian E.","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Gubbiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152398_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152398_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12022-023-09777-x","article-title":"Multilineage pituitary neuroendocrine tumors (PitNETs) expressing PIT1 and SF1","volume":"34","author":"Asa","year":"2023","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152398_bb0015","doi-asserted-by":"crossref","DOI":"10.1227\/neu.0000000000002846","article-title":"Clinical and pathological features of Pit1\/SF1 multilineage pituitary neuroendocrine tumor","author":"Wang","year":"2024","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152398_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00401-024-02686-1","article-title":"Pituitary neuroendocrine tumors with PIT1\/SF1 co-expression show distinct clinicopathological and molecular features","volume":"147","author":"Dottermusch","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152398_bb0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s11102-021-01164-1","article-title":"Double adenomas of the pituitary reveal distinct lineage markers, copy number alterations, and epigenetic profiles","volume":"24","author":"Hagel","year":"2021","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152398_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2004.02055.x","article-title":"Preoperative identification of clearly separated double pituitary adenomas","volume":"61","author":"Kim","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152398_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03343674","article-title":"Double adenoma of the pituitary: a somatotroph adenoma colliding with a gonadotroph adenoma","volume":"23","author":"Syro","year":"2000","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.anndiagpath.2024.152398_bb0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/01.MP.0000030451.28828.00","article-title":"A case of Cushing\u2019s disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism","volume":"15","author":"Tahara","year":"2002","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152398_bb0045","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3171\/2022.12.JNS222118","article-title":"Pituitary adenomas with multiple cell lineage combinations: clinicopathological features and short-term prognosis","volume":"139","author":"Tang","year":"2023","journal-title":"J Neurosurg"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152398_bb0050","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0328","article-title":"Somatostatin receptor expression and clinical outcome of multilineage pituitary tumours expressing PIT1 and SF1","volume":"12","author":"Fookeerah","year":"2023","journal-title":"Endocr Connect"},{"key":"10.1016\/j.anndiagpath.2024.152398_bb0055","article-title":"Clinicopathological correlates of PIT1 and SF1-multilineage pituitary neuroendocrine tumors and the diagnostic utility of NKX2.2 immunohistochemistry in pituitary pathology","author":"Dogukan","year":"2024","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152398_bb0060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/10668969231183712","article-title":"Plurihormonal pituitary neuroendocrine tumours - a single centre experience","volume":"32","author":"Mihajlovic","year":"2024","journal-title":"Int J Surg Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2024.152398_bb0065","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1210\/jcem.86.9.7819","article-title":"Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152398_bb0070","first-page":"163","article-title":"Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients","volume":"20","author":"Mazal","year":"2001","journal-title":"Clin Neuropathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152398_bb0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000533692","article-title":"DNA methylation pattern in somatotroph pituitary neuroendocrine tumors","volume":"114","author":"Kober","year":"2024","journal-title":"Neuroendocrinology"},{"issue":"7697","key":"10.1016\/j.anndiagpath.2024.152398_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T15:59:52Z","timestamp":1733241592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":16,"alternative-id":["S1092913424001357"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152398","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIT-1\/SF-1 co-expression in pituitary neuroendocrine tumors (PitNETs) with comprehensive review of the literature: How should we best characterize these neoplasms?","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152398"}}